Clinical Trial Update: Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Miebo (Perfluorohexyloctane) eyedrops in habitual contact lens wearers for dry eye conditions has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Dry Eye Disease
• Evaporative Dry Eye
• Kerato Conjunctivitis Sicca

Drugs mentioned

• Miebo (perfluorohexyloctane ophthalmic solution)

Snippet

Sponsor: Gordon Schanzlin New Vision | Conditions: Dry Eye, Dry Eye, Evaporative | Phase 4 | Status: COMPLETED